
Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.

Efficacy of Pharmaceutical Care for Patients with Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial
Vol 37, Issue 2, 2023
Abstract
Purpose: Platinum drugs or other chemotherapies are still widely used in treating lung cancer, causing adverse effects on patients’ emotions and quality of life (QoL) the patients. Chemotherapeutic pharmaceutical care is necessary for patients with lung cancer to relieve side effects and enhance therapeutic efficacy. This study aimed to investigate the pharmaceutical care contribution to improvements in cancer-related fatigue (CRF), negative emotions, and QoL in lung cancer patients undergoing chemotherapy. Methods: Patients were divided into control and intervention groups. Patients in the control group received chemotherapy, whereas patients in the intervention group received pharmaceutical care combined with chemotherapy. CRF, negative emotions, and QoL were evaluated throughout the admission and the second and fourth chemotherapy cycles. Results: After two chemotherapy cycles, the intervention group had lower emotional, physical fatigue, and negative-emotion scores (p < 0.01) and higher QoL scores related to emotion, function, and additional lung cancer concerns (p < 0.01) than the control group. Similarly, after four cycles of chemotherapy, the intervention group had lower emotional, physical, cognitive fatigue, and negative emotion scores (p < 0.01) and a better total QoL score (p < 0.01) than the control group. In addition, the remission rate (RR) of patients after receiving pharmaceutical care was significantly increased compared to the group receiving chemotherapy alone (p < 0.05). Conclusions: Pharmaceutical care could significantly improve CRF, negative emotions, and QoL in lung cancer patients undergoing chemotherapy.
Keywords
References
Supporting Agencies
Copyright (c) 2023 Xiangwei Xu, Ankang Li, Penghai Zhang, Yiyuan Xi, Meihong Zhou, Yinqiao Chen
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Medical Genetics, University of Torino Medical School, Italy

Department of Biomedical, Surgical and Dental Sciences, University of Milan, Italy